Recent advancements and application of in vitro models for predicting inhalation toxicity in humans.

In vitro models Inhalation toxicity Organ-on-a-chip Respiratory Toxicogenomics

Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 22 06 2021
revised: 20 11 2021
accepted: 10 12 2021
pubmed: 18 12 2021
medline: 10 2 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

Animals have been indispensable in testing chemicals that can pose a risk to human health, including those delivered by inhalation. In recent years, the combination of societal debate on the use of animals in research and testing, the drive to continually enhance testing methodologies, and technology advancements have prompted a range of initiatives to develop non-animal alternative approaches for toxicity testing. In this review, we discuss emerging in vitro techniques being developed for the testing of inhaled compounds. Advanced tissue models that are able to recreate the human response to toxic exposures alongside examples of their ability to complement in vivo techniques are described. Furthermore, technology being developed that can provide multi-organ toxicity assessments are discussed.

Identifiants

pubmed: 34920082
pii: S0887-2333(21)00224-1
doi: 10.1016/j.tiv.2021.105299
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105299

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

R Bedford (R)

Labcorp Early Development Laboratories Limited, Harrogate, UK. Electronic address: Robert.Bedford@labcorp.com.

E Perkins (E)

Labcorp Early Development Laboratories Limited, Harrogate, UK. Electronic address: Ethan.Perkins@labcorp.com.

J Clements (J)

Labcorp Early Development Laboratories Limited, Harrogate, UK. Electronic address: Julie.Clements@labcorp.com.

M Hollings (M)

Labcorp Early Development Laboratories Limited, Harrogate, UK. Electronic address: Michael.Hollings@labcorp.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH